Alex Zhavoronkov — AI Voice Profile | Payloop

A

Alex Zhavoronkov

CEO at Insilico Medicine

Posts tracked from 6/20/2023 to 4/29/2026

Posts Analyzed

86

Platforms

2

Total Engagement

0

Positive Sentiment

84%

72 positive of 86

Tools Discussed by Alex Zhavoronkov

Clari

ai-sales

Exa

ai-search

Ema

ai-finance

Nomic

llm-provider · 1,878 stars

Share: Twitter LinkedIn

Developer Profile

20

npm packages

104.1M

weekly downloads

Posts by Platform

Alex Zhavoronkov

Alex Zhavoronkov's Insilico Medicine raised $500 million and has made significant progress in drug development.

fundingbiotech

Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs)

Alex Zhavoronkov will be speaking at BIO 2026 about the applications of AI in longevity and drug discovery.

ai longevitydrug discovery

AI Longevity Pioneer Alex Zhavoronkov Named to ...

Alex Zhavoronkov has been recognized as a pioneer in AI longevity by being named to Business Insider's inaugural 'Rising Stars of Longevity' list.

ai longevityrising stars

Team

Alex Zhavoronkov serves as the Chairman and CEO of Insilico Medicine, leading a team of experts.

teamleadership

AI Evolution: Scaling Therapeutic Programs

CEO Alex Zhavoronkov shares his vision for the future of pharmaceutical intelligence and therapeutic programs over the next five years.

ai evolutionpharmaceuticals

Avg engagement: 0Total: 0

Activity Timeline

Top Topics

ai25longevity14healthcare13drug discovery10ai drug discovery8ai healthcare7biotechnology6biotech5generative ai5pharmaceuticals5drug development4interview4aging research3consumer use3ai in drug discovery3ai drug development3aging3innovation3ai leadership3disease treatment3

Platform Distribution

Sentiment Overview

positive

84%72

neutral

16%14

negative

0%0

Top Keywords

alex zhavoronkov76ai61insilico medicine35drug discovery16longevity13drug development8healthcare8generative ai7insilico7doctors5biotechnology5lilly4idiopathic pulmonary fibrosis4pharma3robotics3health questions3biotech3treatment3pill3bio 20262leadership2aging2pharmaceutical2superintelligence2clinical trials2

Recent Posts

web

Alex Zhavoronkov

fundingbiotech

web

Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs)

ai longevitydrug discovery

news

Their CEO, Alex Zhavoronkov, told CNBC that Insilico has ...

drug developmentgenerative ai

news

Alex Zhavoronkov's Post

academic transitionai communication

web

AI Longevity Pioneer Alex Zhavoronkov Named to ...

ai longevityrising stars

news

Hong Kong-listed Insilico Medicine has reached a deal ...

airobotics

web

Team

teamleadership

news

AI can be used by consumers for basic health questions ...

ai healthcareconsumer use

news

AI can be used by consumers for basic health questions ...

ai healthcareconsumer use

news

Alex Zhavoronkov, PhD

ai drug discoveryaging research

news

AI can be used by consumers for basic health questions ...

ai healthcareconsumer use

news

$2.8B Says AI Wins: Why Lilly Backed AI Drug Discovery ...

ai drug discoveryinvestment

web

AI Evolution: Scaling Therapeutic Programs

ai evolutionpharmaceuticals

web

Alex Zhavoronkov - AI for Good - ITU

aibiotechnology

web

AI-powered therapeutic target discovery

therapeutic discoveryai applications

news

Insilico Medicine's AI Develops Brain Tumor Drug in Six ...

ai in drug discoverymedical research

news

Alex Zhavoronkov, Insilico Medicine | AI Drug Development ...

ai drug developmentlongevity

news

Insilico Medicine's AI-Driven Roadmap for Pharmaceutical ...

aidrug discovery

web

Progress, Pitfalls, and Impact of AI-Driven Clinical Trials

aiclinical trials

news

Alex Zhavoronkov's Post

ai applicationspulmonary fibrosis